Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance - an experimental study.

Katsumata H, Miyairi S, Ikemiyagi M, Hirai T, Fukuda H, Kanzawa T, Ishii R, Saiga K, Ishii Y, Omoto K, Okumi M, Yokoo T, Tanabe K.

Transpl Int. 2019 Apr;32(4):443-453. doi: 10.1111/tri.13390. Epub 2019 Jan 23.

PMID:
30561097
2.

Impact of activated invariant natural killer T cells on the expansion of regulatory T cell precursors in murine thymocytes in vitro.

Katsumata H, Ikemiyagi M, Hirai T, Kanzawa T, Ishii R, Miyairi S, Fukuda H, Saiga K, Okumi M, Ishii Y, Yokoo T, Tanabe K.

Immunol Lett. 2019 Feb;206:41-48. doi: 10.1016/j.imlet.2018.11.013. Epub 2018 Nov 29.

PMID:
30503823
3.

In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.

Yagisawa T, Tanaka T, Miyairi S, Tanabe K, Dvorina N, Yokoyama WM, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Kidney Int. 2019 Feb;95(2):350-362. doi: 10.1016/j.kint.2018.08.041. Epub 2018 Nov 29.

PMID:
30503624
4.

Peritransplant VLA-4 blockade inhibits endogenous memory CD8 T cell infiltration into high-risk cardiac allografts and CTLA-4Ig resistant rejection.

Iida S, Miyairi S, Su CA, Abe T, Abe R, Tanabe K, Dvorina N, Baldwin WM 3rd, Fairchild RL.

Am J Transplant. 2018 Oct 29. doi: 10.1111/ajt.15147. [Epub ahead of print]

PMID:
30372587
5.

Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.

Tanaka T, Ohashi S, Saito H, Wada T, Aoyama T, Ichimaru Y, Miyairi S, Kobayashi S.

Biochem Biophys Res Commun. 2018 Jan 29;496(1):7-11. doi: 10.1016/j.bbrc.2017.12.106. Epub 2017 Dec 21.

PMID:
29274785
6.

Indirubin derivatives protect against endoplasmic reticulum stress-induced cytotoxicity and down-regulate CHOP levels in HT22 cells.

Kosuge Y, Saito H, Haraguchi T, Ichimaru Y, Ohashi S, Miyagishi H, Kobayashi S, Ishige K, Miyairi S, Ito Y.

Bioorg Med Chem Lett. 2017 Dec 1;27(23):5122-5125. doi: 10.1016/j.bmcl.2017.10.069. Epub 2017 Oct 28.

PMID:
29122482
7.

iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.

Ishii R, Hirai T, Miyairi S, Omoto K, Okumi M, Ishii Y, Tanabe K.

Am J Transplant. 2018 Feb;18(2):328-340. doi: 10.1111/ajt.14453. Epub 2017 Sep 15.

8.

5-Bromoindirubin 3'-(O-oxiran-2-ylmethyl)oxime: A long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase.

Ichimaru Y, Fujii T, Saito H, Sano M, Uchiyama T, Miyairi S.

Bioorg Med Chem. 2017 Sep 1;25(17):4665-4676. doi: 10.1016/j.bmc.2017.07.009. Epub 2017 Jul 8.

PMID:
28743492
9.

Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.

Sano M, Ichimaru Y, Kurita M, Hayashi E, Homma T, Saito H, Masuda S, Nemoto N, Hemmi A, Suzuki T, Miyairi S, Hao H.

Cancer Lett. 2017 Jul 1;397:72-82. doi: 10.1016/j.canlet.2017.03.031. Epub 2017 Mar 24.

PMID:
28347789
10.

Transitional B Cells Predominantly Reconstituted After a Desensitization Therapy Using Rituximab Before Kidney Transplantation.

Ikemiyagi M, Hirai T, Ishii R, Miyairi S, Okumi M, Tanabe K.

Ther Apher Dial. 2017 Apr;21(2):139-149. doi: 10.1111/1744-9987.12508. Epub 2017 Mar 13.

PMID:
28296027
11.

Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.

Miyairi S, Hirai T, Ishii R, Okumi M, Nunoda S, Yamazaki K, Ishii Y, Tanabe K.

Eur J Immunol. 2017 Apr;47(4):734-742. doi: 10.1002/eji.201646670. Epub 2017 Mar 21.

12.

Indirubin 3'-Epoxide Induces Caspase-Independent Cell Death in Human Neuroblastoma.

Kurita M, Hanada S, Ichimaru Y, Saito H, Tabata K, Asami S, Miyairi S, Suzuki T.

Biol Pharm Bull. 2016;39(6):993-9. doi: 10.1248/bpb.b15-00999.

13.

Neuroprotective effect of S-allyl-l-cysteine derivatives against endoplasmic reticulum stress-induced cytotoxicity is independent of calpain inhibition.

Imai T, Kosuge Y, Saito H, Uchiyama T, Wada T, Shimba S, Ishige K, Miyairi S, Makishima M, Ito Y.

J Pharmacol Sci. 2016 Mar;130(3):185-8. doi: 10.1016/j.jphs.2016.03.004. Epub 2016 Mar 14.

14.

Indirubin, a component of Ban-Lan-Gen, activates CYP3A4 gene transcription through the human pregnane X receptor.

Kumagai T, Aratsu Y, Sugawara R, Sasaki T, Miyairi S, Nagata K.

Drug Metab Pharmacokinet. 2016 Apr;31(2):139-45. doi: 10.1016/j.dmpk.2016.01.002. Epub 2016 Jan 22.

PMID:
26987505
15.

Clonal Deletion Established via Invariant NKT Cell Activation and Costimulatory Blockade Requires In Vivo Expansion of Regulatory T Cells.

Hirai T, Ishii R, Miyairi S, Ikemiyagi M, Omoto K, Ishii Y, Tanabe K.

Am J Transplant. 2016 Feb;16(2):426-39. doi: 10.1111/ajt.13493. Epub 2015 Oct 23.

16.

Promotion of acute-phase skin wound healing by Pseudomonas aeruginosa C4 -HSL.

Kanno E, Kawakami K, Miyairi S, Tanno H, Suzuki A, Kamimatsuno R, Takagi N, Miyasaka T, Ishii K, Gotoh N, Maruyama R, Tachi M.

Int Wound J. 2016 Dec;13(6):1325-1335. doi: 10.1111/iwj.12523. Epub 2015 Oct 16.

PMID:
26471357
17.

Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.

Ichimaru Y, Saito H, Uchiyama T, Metori K, Tabata K, Suzuki T, Miyairi S.

Bioorg Med Chem Lett. 2015 Apr 1;25(7):1403-6. doi: 10.1016/j.bmcl.2015.02.053. Epub 2015 Feb 28.

PMID:
25765906
18.

Indirubin derivatives alter DNA binding activity of the transcription factor NF-Y and inhibit MDR1 gene promoter.

Tanaka T, Ohashi S, Saito H, Higuchi T, Tabata K, Kosuge Y, Suzuki T, Miyairi S, Kobayashi S.

Eur J Pharmacol. 2014 Oct 15;741:83-9. doi: 10.1016/j.ejphar.2014.07.035. Epub 2014 Jul 24.

PMID:
25066113
19.

Redo mitral valve replacement using the valve-on-valve method.

Miyairi S, Koide M, Kunii Y, Tsuda K, Ohashi Y, Harada T.

Asian Cardiovasc Thorac Ann. 2015 Jul;23(6):707-9. doi: 10.1177/0218492314524206. Epub 2014 Feb 17.

PMID:
24585313
20.

Supplemental Content

Loading ...
Support Center